e-learning
resources
European Respiratory Review
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Guidance production before evidence generation for critical issues: the example of COVID-19
Nicolas Roche, Thomy Tonia, Andrew Bush, Chris Brightling, Martin Kolb, Anh Tuan Dinh-Xuan, Marc Humbert, Anita Simonds, Yochai Adir
Source:
Eur Respir Rev, 29 (157) 200310; 10.1183/16000617.0310-2020
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nicolas Roche, Thomy Tonia, Andrew Bush, Chris Brightling, Martin Kolb, Anh Tuan Dinh-Xuan, Marc Humbert, Anita Simonds, Yochai Adir. Guidance production before evidence generation for critical issues: the example of COVID-19. Eur Respir Rev, 29 (157) 200310; 10.1183/16000617.0310-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Producing documents for the ERS: types, requirements and processes
Source: Annual Congress 2013 –How to produce top quality ERS Guidelines
Year: 2013
Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects
Source: International Congress 2017 – In the frontline of the fight against tuberculosis
Year: 2017
Evidence provided by recent meta-analyses on treatment: what is new?
Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Year: 2012
Formulating recommendations and identifying areas of future research - Panel discussion and protocol
Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs)
Year: 2009
Universal use of face masks for success against COVID-19: evidence and implications for prevention policies
Source: Eur Respir J, 55 (6) 2001260; 10.1183/13993003.01260-2020
Year: 2020
Candidate selection and management: specific controversial and ethical issues
Source: ERS Course 2016
Year: 2016
Establishing new treatments: the role of RCTs
Source: Virtual Congress 2020 – Tuberculosis: learning from the WHO global health emergencies
Year: 2020
Late Breaking Abstract - Evidence of target engagement and pathway modulation: biomarker analysis of the phase 1b inhaled seralutinib study
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement
Source: Eur Respir J 2016; 47:1336-1341
Year: 2016
Panel discussion: identify concrete areas/topics where collaboration at EU-level is necessary.
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013
Harnessing big data for evaluation and regulation of medicines
Source: Virtual Congress 2021 – Artificial intelligence and big data
Year: 2021
Describing what evidence and outcomes to use in guidelines
Source: Annual Congress 2008 - Guideline development workshop summary: ATS/ERS integrating and coordinating efforts in COPD
Year: 2008
Targeting the arginase pathway: potential developments as new avenues for treatment
Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma?
Year: 2004
Prevention: educational issues and recommendations for early recognition
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=89
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept